Put it’s simple:
- NYR 19 million market cap in a 60 billion dollar unmet market with the only drug in the world to treat primary, secondary brain injury and cardiovascular protection during all strokes
Safety in humans starts next week and we will know in 28 days of the first cohort results. Relax and enjoy biotech because like its peers in this space the ROI is multiples on each milestone now it’s officially in the clinic
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $69.60M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.3¢ | 32.5¢ | $195.9K | 589.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14970 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 20100 | 1 |
View Market Depth
| Last trade - 15.29pm 25/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |